Sutro Biopharma, Inc. (STRO)
NASDAQ: STRO · Real-Time Price · USD
1.010
+0.129 (14.68%)
At close: Oct 17, 2025, 4:00 PM EDT
1.030
+0.020 (1.98%)
After-hours: Oct 17, 2025, 7:59 PM EDT

Sutro Biopharma Revenue

Sutro Biopharma had revenue of $63.75M in the quarter ending June 30, 2025, with 147.98% growth. This brings the company's revenue in the last twelve months to $104.47M, down -38.31% year-over-year. In the year 2024, Sutro Biopharma had annual revenue of $62.04M, down -59.64%.

Revenue (ttm)
$104.47M
Revenue Growth
-38.31%
P/S Ratio
0.80
Revenue / Employee
$337,010
Employees
310
Market Cap
85.62M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202462.04M-91.69M-59.64%
Dec 31, 2023153.73M85.96M126.84%
Dec 31, 202267.77M5.89M9.52%
Dec 31, 202161.88M19.16M44.84%
Dec 31, 202042.72M-14.00K-0.03%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro